Medisys, Roche Settle Patent Row Over Diabetics Device
Hypoguard USA Inc., the operator of Medisys’ U.S. blood glucose monitoring business, has settled a patent case that Roche brought against it and three other companies in 2004. The firm has said the undisclosed settlement is favorable to all parties.
The complaint, filed in the U.S. District Court for the Southern District of Indiana,
To view the full article, register now.